With an insatiable curiosity and an unwavering drive to create new sources of future value, Flagship is dedicated to generating pioneering life sciences companies. Our innovation process is grounded in hypothesis-driven exploration, allowing us to tackle the world’s biggest challenges and conceive disruptive scientific solutions. Through our ventures, we aim to revolutionize the pharmaceutical industry, optimize agricultural practices, and innovate sustainable resources. Our team of entrepreneurial scientists is committed to delivering maximum value, continuously identifying unexplored opportunities and realizing value for society through transformative innovations and ventures. Our approach begins with asking “what if?” and “if only…” and pushing the boundaries of what is possible. We leverage a vast network of academic, startup, and corporate leaders to challenge, hone, and perfect ideas until a compelling value proposition emerges.
158
Total Investments
70
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Biotechnology, Finance +1
Funding Stage
Series A +2
Company Overview
Investment Criteria
Check Size
•••••• — ••••••
Investment Thesis
•••••• •••••• ••••••
About Flagship Pioneering
Recent Investments (158)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series F | •••••• | Jan 2024 | |
| Post Ipo Equity | •••••• | Dec 2023 | |
| Seed Round | •••••• | Nov 2023 | |
| Venture Round | •••••• | Sep 2023 | |
| Series C | •••••• | Sep 2023 | |
|
|
Series B | •••••• | Sep 2023 |
|
|
Series B | •••••• | Aug 2023 |
|
|
Venture Round | •••••• | Jun 2023 |
|
|
Funding Round | •••••• | May 2023 |
|
|
Series C | •••••• | Mar 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.